SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $551,000 | +26.1% | 36,720 | +2.2% | 0.00% | – |
| Q1 2016 | $437,000 | -9.0% | 35,946 | +19.2% | 0.00% | -100.0% |
| Q4 2015 | $480,000 | +26.3% | 30,163 | +21.5% | 0.00% | 0.0% |
| Q3 2015 | $380,000 | -49.3% | 24,816 | -19.5% | 0.00% | 0.0% |
| Q2 2015 | $750,000 | +34.9% | 30,829 | +29.1% | 0.00% | 0.0% |
| Q1 2015 | $556,000 | +54.0% | 23,879 | +66.2% | 0.00% | – |
| Q4 2014 | $361,000 | -7.4% | 14,365 | +14.4% | 0.00% | – |
| Q3 2014 | $390,000 | +18.9% | 12,556 | -1.3% | 0.00% | – |
| Q2 2014 | $328,000 | +15.1% | 12,718 | +4.5% | 0.00% | – |
| Q1 2014 | $285,000 | +5.2% | 12,173 | +13.9% | 0.00% | – |
| Q4 2013 | $271,000 | +39.7% | 10,683 | +12.5% | 0.00% | – |
| Q3 2013 | $194,000 | – | 9,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,495,416 | $97,301,000 | 26.57% |
| Stonepine Capital Management, LLC | 356,307 | $5,337,000 | 5.47% |
| Penn Capital Management Company, LLC | 1,841,035 | $27,673,000 | 1.57% |
| SECTORAL ASSET MANAGEMENT INC | 1,008,265 | $15,104,000 | 1.56% |
| Tamarack Advisers, LP | 259,336 | $3,885,000 | 1.49% |
| THB ASSET MANAGEMENT | 632,499 | $9,474,000 | 1.23% |
| JW Asset Management, LLC | 101,630 | $1,522,000 | 1.21% |
| Healthcare Value Capital, LLC | 50,000 | $749,000 | 0.91% |
| Kerrisdale Advisers, LLC | 190,372 | $2,851,000 | 0.77% |
| Healthcare Value Capital, LLC | 35,000 | $524,000 | 0.64% |